TNF and rheumatoid arthritis: This is notable in the context of RA 57, 58 success of this is particularly evident in the instance of TNFα targeted therapies, chiefly validating TNFα as a target and subsequent development of a variety of drugs to target this pro‐inflammatory cytokine 59, 60.